FDA issues first EUA for sample pooling in dx testing

Create PDF

The Quest test, initially authorized on March 17, remains authorized to test individual samples from people with suspected COVID-19 infection. The test is authorized for use with individual nasal swab specimens that are self-collected at home or in a health care setting using an authorized home-collection kit when determined to be appropriate by a health care provider.